PHASE-II STUDY OF VP16-213 (ETOPOSIDE) IN REFRACTORY METASTATIC BREAST-CARCINOMA

被引：0

作者：

SCHELL, FC ^{[1
]}

YAP, HY ^{[1
]}

HORTOBAGYI, GN ^{[1
]}

ISSELL, B ^{[1
]}

ESPARZA, L ^{[1
]}

机构：

[1] BRISTOL MYERS CO LABS,SYRACUSE,NY 13201

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：223 / 225

页数：3

共 15 条

[1]

BRODER LE, 1974, CANCER TREAT REV, V1, P183, DOI 10.1016/S0305-7372(74)80002-2

[2]

BUZDAR AU, 1978, CANCER, V41, P392, DOI 10.1002/1097-0142(197802)41:2<392::AID-CNCR2820410202>3.0.CO

[3]

2-7

[4]

CANNELIOS GP, 1976, ANN INTERN MED, V84, P389

[5]

CARDENAS JO, 1975, AM SOC CLIN ONCOL, V16, P231

[6]

Carter S K, 1974, Semin Oncol, V1, P131

[7]

DELENA M, 1975, CANCER, V35, P1108, DOI 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO

[8]

2-Z

[9]

HORTOBAGYI GN, 1977, RECENT RES CANCER, V62, P143

[10] ETOPOSIDE (VP-16-213) [J].

ISSELL, BF ;

CROOKE, ST .